These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 37152370)

  • 21. Prognostic analysis of
    Li D; Fan X; Zuo L; Wu X; Wu Y; Zhang Y; Zou F; Sun Z; Zhang W
    Ann Transl Med; 2022 Dec; 10(24):1356. PubMed ID: 36660710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predicting the immunity landscape and prognosis with an NCLs signature in liver hepatocellular carcinoma.
    Ji Z; Zhang C; Yuan J; He Q; Zhang X; Yang D; Xu N; Chu J
    PLoS One; 2024; 19(4):e0298775. PubMed ID: 38662757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA Damage Repair Status Predicts Opposite Clinical Prognosis Immunotherapy and Non-Immunotherapy in Hepatocellular Carcinoma.
    Chen Y; Wang X; Deng X; Zhang Y; Liao R; Li Y; Yang H; Chen K
    Front Immunol; 2021; 12():676922. PubMed ID: 34335575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.
    Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A
    Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of hepatocellular carcinoma-related subtypes and development of a prognostic model: a study based on ferritinophagy-related genes.
    Wang G; Li J; Zhu L; Zhou Z; Ma Z; Zhang H; Yang Y; Niu Q; Wang X
    Discov Oncol; 2023 Aug; 14(1):147. PubMed ID: 37555866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A scoring model based on ferroptosis genes for prognosis and immunotherapy response prediction and tumor microenvironment evaluation in liver hepatocellular carcinoma.
    Gao L; Xue J; Liu X; Cao L; Wang R; Lei L
    Aging (Albany NY); 2021 Nov; 13(22):24866-24881. PubMed ID: 34839280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic prediction using a gene signature developed based on exhausted T cells for liver cancer patients.
    Zhou Y; Wu W; Cai W; Zhang D; Zhang W; Luo Y; Cai F; Shi Z
    Heliyon; 2024 Mar; 10(6):e28156. PubMed ID: 38533068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Levels of DEAH-Box Helicases Relate to Poor Prognosis and Reduction of DHX9 Improves Radiosensitivity of Hepatocellular Carcinoma.
    Chen X; Lin L; Chen G; Yan H; Li Z; Xiao M; He X; Zhang F; Zhang Y
    Front Oncol; 2022; 12():900671. PubMed ID: 35814441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive analysis of diverse programmed cell death patterns in the prognosis, tumor microenvironment and drug sensitivity in hepatocellular carcinoma.
    Yu Y; Lou Y; Zhu J; Wang X
    Medicine (Baltimore); 2023 Dec; 102(48):e36239. PubMed ID: 38050240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A disulfidptosis-related lncRNAs signature in hepatocellular carcinoma: prognostic prediction, tumor immune microenvironment and drug susceptibility.
    Liu Y; Meng J; Ruan X; Wei F; Zhang F; Qin X
    Sci Rep; 2024 Jan; 14(1):746. PubMed ID: 38185671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a brand intratumor microbiome signature for predicting prognosis of hepatocellular carcinoma.
    Song Y; Xiang Z; Lu Z; Su R; Shu W; Sui M; Wei X; Xu X
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11319-11332. PubMed ID: 37380815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BUB1 predicts poor prognosis and immune status in liver hepatocellular carcinoma.
    Qi W; Bai Y; Wang Y; Liu L; Zhang Y; Yu Y; Chen H
    APMIS; 2022 Jul; 130(7):371-382. PubMed ID: 35255180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma.
    Luo Y; Liu H; Fu H; Ding GS; Teng F
    Front Immunol; 2022; 13():974377. PubMed ID: 36458010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prognostic and Therapeutic Role of Histone Acetylation Modification in LIHC Development and Progression.
    Gao J; Han S; Gu J; Wu C; Mu X
    Medicina (Kaunas); 2023 Sep; 59(9):. PubMed ID: 37763801
    [No Abstract]   [Full Text] [Related]  

  • 35. An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma.
    Yao N; Jiang W; Wang Y; Song Q; Cao X; Zheng W; Zhang J
    Eur J Med Res; 2023 Mar; 28(1):123. PubMed ID: 36918943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and analysis of necroptosis-associated signatures for prognostic and immune microenvironment evaluation in hepatocellular carcinoma.
    Lu J; Yu C; Bao Q; Zhang X; Wang J
    Front Immunol; 2022; 13():973649. PubMed ID: 36081504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma.
    Wu X; Jin B; Liu X; Mao Y; Wan X; Du S
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10319-10333. PubMed ID: 37273105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N6-methyladenosine (m6A) RNA methylation regulator SNRPC is a prognostic biomarker and is correlated with immunotherapy in hepatocellular carcinoma.
    Cai J; Zhou M; Xu J
    World J Surg Oncol; 2021 Aug; 19(1):241. PubMed ID: 34389000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prognostic exosome-related long non-coding RNAs risk model related to the immune microenvironment and therapeutic responses for patients with liver hepatocellular carcinoma.
    Yue Y; Tao J; An D; Shi L
    Heliyon; 2024 Jan; 10(2):e24462. PubMed ID: 38293480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.